1 Aug 2026Open access
Denecimig (Mim8) Prophylaxis in Children With Haemophilia A With or Without Factor VIII InhibitorsPublisher siteResearch and Practice in Thrombosis and Haemostasis, Hemophilia Treatment and Research
Active, last published 2026
In hemophilia treatment and research
Johnny
Mahlangu
Scholar“Research focused on Hemophilia Treatment and Research and adjacent fields.”
University of the Witwatersrand
South Africa47
H-index
13.6k
Citations
Johnny has not officially claimed their profile. If you are Johnny, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohnny Mahlangu is a researcher working on Hemophilia Treatment and Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Johnny's work has been cited 13,569 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hemophilia Treatment and Research×243Platelet Disorders and Treatments×82Coagulation, Bradykinin, Polyphosphates, and Angioedema×52Blood Coagulation and Thrombosis Mechanisms×44Chronic Myeloid Leukemia Treatments×35
04 · Where I am
Affiliations
Affiliation on published researchUniversity of the Witwatersrand, South AfricaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
24 works8 Jul 2026
Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapiesPublisher siteExpert Review of Hematology, Hemophilia Treatment and Research
1 Feb 2026
Efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transferPublisher siteHämostaseologie, Virus-based gene therapy research
25 Oct 2025Open access7cites
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025Publisher siteHaemophilia, Hemophilia Treatment and Research
1 Jun 2025Open access
A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial DesignPublisher siteJournal of sickle cell disease., Hemoglobinopathies and Related Disorders
1 Jan 2025Open access
Occult hepatitis B virus infection in people with haemophilia in South AfricaPublisher siteThe Journal of Haemophilia Practice, Hepatitis B Virus Studies
31 Dec 2024Open access8cites
Adeno-associated virus-based gene therapy for hemophilia–addressing the gapsPublisher siteResearch and Practice in Thrombosis and Haemostasis, Virus-based gene therapy research
15 Dec 2024Open access1cites
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitorsPublisher siteHaemophilia, Hemophilia Treatment and Research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Johnny?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you